Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns.

Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS.

Am J Surg Pathol. 2018 Jul 11. doi: 10.1097/PAS.0000000000001118. [Epub ahead of print]

PMID:
30001234
2.

Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant.

Liu W, Liu Q, Wang W, Wang P, Chen J, Hong T, Zhang N, Li B, Qu Q, He X.

J Cancer. 2018 Apr 19;9(10):1804-1812. doi: 10.7150/jca.25093. eCollection 2018.

3.

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.

Cuenco J, Wehnert N, Blyuss O, Kazarian A, Whitwell HJ, Menon U, Dawnay A, Manns MP, Pereira SP, Timms JF.

Oncotarget. 2018 Apr 3;9(25):17430-17442. doi: 10.18632/oncotarget.24732. eCollection 2018 Apr 3.

4.

The significance of serum IgG4 and CA19-9, autoantibodies in diagnosis and differential diagnosis of IgG4-related sclerosing cholangitis.

Tan L, Guan X, Zeng T, Wu S, Zheng W, Fu H, Long T, Wang Q, Meng Y, Tian Y, Yu J, Chen J, Li H, Cao L.

Scand J Gastroenterol. 2018 Feb;53(2):206-211. doi: 10.1080/00365521.2017.1416159. Epub 2017 Dec 22.

PMID:
29272982
5.

CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.

Loosen SH, Roderburg C, Kauertz KL, Koch A, Vucur M, Schneider AT, Binnebösel M, Ulmer TF, Lurje G, Schoening W, Tacke F, Trautwein C, Longerich T, Dejong CH, Neumann UP, Luedde T.

Sci Rep. 2017 Dec 5;7(1):16975. doi: 10.1038/s41598-017-17175-7.

6.

Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.

Gossard AA, Gores GJ.

Clin Liver Dis. 2017 Nov;21(4):725-737. doi: 10.1016/j.cld.2017.06.004. Epub 2017 Jul 25. Review.

PMID:
28987259
7.

Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.

Boyd S, Vannas M, Jokelainen K, Isoniemi H, Mäkisalo H, Färkkilä MA, Arola J.

World J Gastroenterol. 2017 Sep 7;23(33):6147-6154. doi: 10.3748/wjg.v23.i33.6147.

8.

Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.

Loosen SH, Roderburg C, Kauertz KL, Pombeiro I, Leyh C, Benz F, Vucur M, Longerich T, Koch A, Braunschweig T, Ulmer TF, Heidenhain C, Tacke F, Binnebösel M, Schmeding M, Trautwein C, Neumann UP, Luedde T.

J Hepatol. 2017 Oct;67(4):749-757. doi: 10.1016/j.jhep.2017.06.020. Epub 2017 Jun 29.

PMID:
28668580
9.

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.

Aabakken L, Karlsen TH, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau JM, Färkkilä M, Fickert P, Hirschfield GM, Laghi A, Marzioni M, Fernandez M, Pereira SP, Pohl J, Poley JW, Ponsioen CY, Schramm C, Swahn F, Tringali A, Hassan C.

Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. Epub 2017 Apr 18.

10.

IgG4-related sclerosing cholangitis overlapping with autoimmune hepatitis: Report of a case.

Li H, Sun L, Brigstock DR, Qi L, Gao R.

Pathol Res Pract. 2017 May;213(5):565-569. doi: 10.1016/j.prp.2017.01.024. Epub 2017 Feb 10.

PMID:
28238541
11.

Biliary Intraepithelial Neoplasia (BilIN) in Primary Sclerosing Cholangitis: The First Report from Iran.

Akbarzadeh L, Geramizadeh B, Kazemi K, Nikeghbalian S, Malekhosseini S.

Hepat Mon. 2016 Dec 14;16(12):e38726. doi: 10.5812/hepatmon.38726. eCollection 2016 Dec.

12.

Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.

Boyd S, Mustonen H, Tenca A, Jokelainen K, Arola J, Färkkilä MA.

Scand J Gastroenterol. 2017 Feb;52(2):242-249. doi: 10.1080/00365521.2016.1250281. Epub 2016 Nov 3.

PMID:
27806633
13.

Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.

Loosen SH, Benz F, Niedeggen J, Schmeding M, Schüller F, Koch A, Vucur M, Tacke F, Trautwein C, Roderburg C, Neumann UP, Luedde T.

Clin Transl Med. 2016 Dec;5(1):39. Epub 2016 Sep 27.

14.

Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.

Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.

Tumour Biol. 2016 Nov;37(11):15019-15029. Epub 2016 Sep 22.

PMID:
27658773
15.

A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis.

Wannhoff A, Folseraas T, Brune M, Rupp C, Friedrich K, Knierim J, Weiss KH, Sauer P, Flechtenmacher C, Schirmacher P, Stremmel W, Hov JR, Gotthardt DN.

United European Gastroenterol J. 2016 Feb;4(1):84-91. doi: 10.1177/2050640615581577. Epub 2015 Apr 9.

16.

Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants.

Lehrke HD, Heimbach JK, Wu TT, Jenkins SM, Gores GJ, Rosen CB, Mounajjed T.

Am J Surg Pathol. 2016 Apr;40(4):510-8. doi: 10.1097/PAS.0000000000000588.

PMID:
26752544
17.

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.

Folseraas T, Boberg KM.

Clin Liver Dis. 2016 Feb;20(1):79-98. doi: 10.1016/j.cld.2015.08.014. Epub 2015 Oct 21. Review.

PMID:
26593292
18.
19.

Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis.

Wannhoff A, Rupp C, Friedrich K, Brune M, Knierim J, Flechtenmacher C, Sauer P, Stremmel W, Hov JR, Schirmacher P, Weiss KH, Gotthardt DN.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2372-9. doi: 10.1016/j.cgh.2015.07.014. Epub 2015 Jul 17.

PMID:
26192140
20.

[Long-term survivor of unresectable bile duct cancer complicated with sclerosing cholangitis treated with chemotherapy].

Okazaki T, Ajiki T, Shinozaki K, Yoshida Y, Murakami S, Matsumoto T, Shinzeki M, Matsumoto I, Fukumoto T, Ku Y.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1542-4. Japanese.

PMID:
25731246

Supplemental Content

Loading ...
Support Center